Zhejiang Cancer Hospital-Oncology ( Site 2612)

Hangzhou, Zhejiang 310022

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Non-Small Cell Lung Cancer

Studies at this site

• Study of Pembrolizumab/Vibostolimab Coformulation (MK-7684A) in Combination With Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (MK-7684A-007/KEYVIBE-007) — Completed